Clinical Trials Insight: 700012672

Trial Profile

Clinical Trials Insight: 700012672

Phase of Trial: Phase III

Latest Information Update: 16 Mar 2006

At a glance

  • Drugs Gabapentin enacarbil (Primary)
  • Indications Restless legs syndrome
  • Focus Adverse reactions; Registrational
  • Sponsors XenoPort
  • Most Recent Events

    • 16 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top